標(biāo)題: Titlebook: Imaging in Clinical Oncology; Athanasios D. Gouliamos,John Andreou,Paris Kosmidi Book 20141st edition Springer-Verlag Italia 2014 Chemothe [打印本頁] 作者: ominous 時(shí)間: 2025-3-21 20:10
書目名稱Imaging in Clinical Oncology影響因子(影響力)
書目名稱Imaging in Clinical Oncology影響因子(影響力)學(xué)科排名
書目名稱Imaging in Clinical Oncology網(wǎng)絡(luò)公開度
書目名稱Imaging in Clinical Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Imaging in Clinical Oncology被引頻次
書目名稱Imaging in Clinical Oncology被引頻次學(xué)科排名
書目名稱Imaging in Clinical Oncology年度引用
書目名稱Imaging in Clinical Oncology年度引用學(xué)科排名
書目名稱Imaging in Clinical Oncology讀者反饋
書目名稱Imaging in Clinical Oncology讀者反饋學(xué)科排名
作者: 爭(zhēng)吵 時(shí)間: 2025-3-21 21:44 作者: 責(zé)怪 時(shí)間: 2025-3-22 02:33
Clinical Implications of Bone SarcomasFirst study should be a plain X-ray of the affected area, followed by CT or MRI.作者: adjacent 時(shí)間: 2025-3-22 05:31
Conventional Imaging in the Diagnosis of Brain TumorsThe imaging features of various neoplasms in the central nervous system (CNS) are reviewed using the currently available diagnostic modalities. The advantages of each method in improving sensitivity and specificity in the diagnosis of CNS tumors are underlined.作者: magnate 時(shí)間: 2025-3-22 10:00
Introduction to Bone Sarcomass, with soft tissue sarcomas being around 80?% off all sarcomas. Bone sarcomas are seen more often in childhood (except chondrosarcomas) while soft tissue sarcomas predominate in the elderly. Since they have distinct features they will be discussed separately [.].作者: 痛恨 時(shí)間: 2025-3-22 15:27 作者: AGGER 時(shí)間: 2025-3-22 20:34
http://image.papertrans.cn/i/image/461725.jpg作者: vertebrate 時(shí)間: 2025-3-22 22:04 作者: 不開心 時(shí)間: 2025-3-23 04:18 作者: 我不怕犧牲 時(shí)間: 2025-3-23 05:55 作者: 損壞 時(shí)間: 2025-3-23 10:48
Arkadios Chr. Rousakis,John A. Andreouon being proposed. Solid tumors establish a vasculature through angiogenesis, vasculogenesis, vascular remodeling, co-option, and possibly also intussusception and vascular mimicry. Quantitative measurements of the tumor vasculature have generally measured the number of microvessels, highlighted usi作者: anesthesia 時(shí)間: 2025-3-23 16:53 作者: confide 時(shí)間: 2025-3-23 18:16 作者: 小故事 時(shí)間: 2025-3-24 02:03
Georgia Ch. Papaioannou,Kieran J. McHughe during the apoptotic process. However, if signals instructing cells to carry out apoptosis are lost, a variety of malignant disorders may result. Normal mammary gland development is controlled by a balance between cell proliferation and apoptosis, and the balance is important for normal mammary gl作者: 疲憊的老馬 時(shí)間: 2025-3-24 04:29
y, it was introduced 50 years ago to downsize locally advanced (inoperable) BCs. NAT are now widespread and so effective to be used also at the early stage of the disease. NAT are heterogeneous in terms of therapeutic patterns, class of used drugs, dosage, and duration. The poly-chemotherapy regimen作者: 轉(zhuǎn)向 時(shí)間: 2025-3-24 07:53 作者: abolish 時(shí)間: 2025-3-24 13:29
Ioannis D. Papanastassiou,Nikolaos S. Demertzisd tests to detect the disease, in its early stages. Although several biochemical markers aid in diagnosis, no existing test is sufficiently sensitive and specific for early detection..Currently there is justifiable optimism that the “omics” technologies will deliver the additional tools that will fi作者: 易碎 時(shí)間: 2025-3-24 17:24 作者: 灰姑娘 時(shí)間: 2025-3-24 19:23
Spyros D. Yarmenitisablished. However, it is as a screening tool that mammography makes its unique contribution to the detection and treatment of early breast cancer, and it is in this role that it has received the most visibility and, sometimes, controversy. Despite its limitations, namely decreased sensitivity in pre作者: DRILL 時(shí)間: 2025-3-25 02:23 作者: 敏捷 時(shí)間: 2025-3-25 06:35
Sofia N. Chatziioannou,Nikoletta K. Pianoud rapidly. The World Health Organization outlines a number of important prerequisites to justify implementation of an effective screening program: Target cancer should have a high prevalence and be associated with a high mortality and morbidity; the screening test has to be safe, effective, and acce作者: Console 時(shí)間: 2025-3-25 11:05
Ioannis P. Boukovinasimply copying the existing models in other countries or is it preferable to envisage different possibilities?. it proves impossible to copy the existing models as they stand. They are in most instances studies or trials rather than national mass programmes. Furthermore, a certain number of problems 作者: 改變 時(shí)間: 2025-3-25 14:35 作者: PET-scan 時(shí)間: 2025-3-25 17:37
Dionysis C. Voros,Theodosios C. Theodosopouloson-CSCs, thus eliminating their capacity for self-renewal. Once breast CSCs lose the capacity for self-renewal, they can also lose their resistance to radiotherapy or chemotherapy and ability to invade. In theory, CSC targeted therapy can attack CSCs so effectively that the tumors degenerate. In con作者: 北京人起源 時(shí)間: 2025-3-26 00:01
standard of care for the past 30 years, until aromatase inhibitors (AIs) proved to be superior in preventing disease recurrence and improving breast cancer mortality in post-menopausal women. Nevertheless, women with early breast cancer remain at risk of relapse for at least 15 years after diagnosis作者: Offbeat 時(shí)間: 2025-3-26 03:30 作者: 圍巾 時(shí)間: 2025-3-26 07:35
Athanasios D. Gouliamos,Nicholas J. Patronas6 % increase in the incidence of breast cancer over the last 10 years, but also a doubling of survival rates in the last 40 years. This improvement in outcomes has been contributed to by the evolving management of the disease. The majority of women diagnosed with early breast cancer (Stages I-III) u作者: DEFER 時(shí)間: 2025-3-26 11:31 作者: Malcontent 時(shí)間: 2025-3-26 14:42 作者: 不近人情 時(shí)間: 2025-3-26 19:54
Imaging in Radiation Therapyalities like CT, MRI, and PET/CT offer more anatomical detail of tumor and surrounding tissue and are used to delineate the planning target volume (PTV) and the organs at risk in the planning process. Therefore, we can achieve a more secure staging and a better view of target tumor volume. Computer-作者: Preserve 時(shí)間: 2025-3-27 00:19
Interventional Radiology in Oncologytion or core biopsy under imaging guidance. IR techniques are worldwide used for palliative treatment: Venous, biliary, esophageal, duodenal, enteric, ureteric, or airways obstructions due to malignant compression or infiltration are now being treated almost exclusively by percutaneous or transoral 作者: epicondylitis 時(shí)間: 2025-3-27 01:34
Imaging Principles in Pediatric Oncologygical, and histological characteristics have to be combined with multimodality imaging evaluation. Radiation protection is a major issue in pediatric oncology imaging. Initial diagnostic imaging strongly depends on ultrasound and less on plain film findings, with the exception of bone tumors. Stagin作者: 迅速飛過 時(shí)間: 2025-3-27 06:04 作者: 史前 時(shí)間: 2025-3-27 10:21 作者: auxiliary 時(shí)間: 2025-3-27 14:42
Introduction to Retroperitoneal Tumors. Retroperitoneal sarcomas (RPS) present specific therapeutic challenges because of their location and frequent close association with several vital structures in the retroperitoneum. This proximity to major vessels, visceral organs, axial skeleton, and neural structures may significantly impair the作者: Stress-Fracture 時(shí)間: 2025-3-27 19:00
Conventional Radiology of Bone and Soft Tissue Tumorsction of bone tumors. The most important clinical aspect is patient’s age. The specific radiographic appearances that enable both differential shortening and more accurate tumor characterization are tumor location, lesion margins and zone of transition, periosteal reaction, radiographic opacity and 作者: Magnificent 時(shí)間: 2025-3-28 01:45 作者: 低能兒 時(shí)間: 2025-3-28 06:06 作者: 信條 時(shí)間: 2025-3-28 09:42 作者: 載貨清單 時(shí)間: 2025-3-28 13:17
Clinical Implications of Retroperitoneal Sarcomas. RPS present specific therapeutic challenges because of their location and frequent close association with several vital structures in the retroperitoneum. This proximity to major vessels, visceral organs, axial skeleton, and neural structures may significantly impair the ability to perform a margi作者: pineal-gland 時(shí)間: 2025-3-28 18:19
Introduction to Brain TumorsFrom the late 19th century until today, neuroimaging underwent an amazing development. The imaging modalities of the CNS available to a physician today are many and can provide a considerable amount of information about its anatomy, physiology, and function. Recent advances in computational power an作者: defibrillator 時(shí)間: 2025-3-28 22:47
Book 20141st edition of the currently available imaging modalities of relevance in clinical oncology are covered, and the presentation of a broad spectrum of oncologic diseases (of most organ systems) on these modalities is discussed and illustrated.?The role of multiparametric and multimodality imaging approaches prov作者: Headstrong 時(shí)間: 2025-3-28 23:04 作者: 祖?zhèn)?nbsp; 時(shí)間: 2025-3-29 06:40 作者: 廚師 時(shí)間: 2025-3-29 10:40 作者: ANN 時(shí)間: 2025-3-29 13:50
Interventional Radiology in Oncologyd development of medical devices led to a breakthrough of interventional radiology to potentially curative procedures. Transarterial chemoembolization and thermal tumor ablation are listed among the curative options for certain cancer patients, hence they occupy the major part of this chapter.作者: Respond 時(shí)間: 2025-3-29 16:40
Positron Emission Tomography in Bone and Soft Tissue Tumorsween viable tumor and necrosis is the most important advantage of.F-FDG PET/CT for the detection of local recurrence, but distant recurrence may be depicted as well. As for the monitoring of therapy, .F-FDG PET/CT seems to be an important tool to evaluate treatment efficacy primarily in GIST.作者: Gleason-score 時(shí)間: 2025-3-29 22:52
Introduction to Soft Tissue Sarcomasnew response criteria. Functional imaging plays an essential role in these criteria especially in cases where rigorous evaluation is needed for changing therapeutic strategy. Finally, follow-up protocols are described.作者: 主動(dòng) 時(shí)間: 2025-3-30 03:19 作者: 無價(jià)值 時(shí)間: 2025-3-30 05:16
Imaging Principles in Pediatric Oncologyoncology imaging. Initial diagnostic imaging strongly depends on ultrasound and less on plain film findings, with the exception of bone tumors. Staging and tumor surveillance is performed with more advanced imaging modalities, such as MRI, less often with CT, and nuclear studies.
